Abstract:Protein aggregation is a widespread phenomenon implicated in debilitating diseases like Alzheimer's, Parkinson's, and cataracts, presenting complex hurdles for the field of molecular biology. In this review, we explore the evolving realm of computational methods and bioinformatics tools that have revolutionized our comprehension of protein aggregation. Beginning with a discussion of the multifaceted challenges associated with understanding this process and emphasizing the critical need for precise predictive tools, we highlight how computational techniques have become indispensable for understanding protein aggregation. We focus on molecular simulations, notably molecular dynamics (MD) simulations, spanning from atomistic to coarse-grained levels, which have emerged as pivotal tools in unraveling the complex dynamics governing protein aggregation in diseases such as cataracts, Alzheimer's, and Parkinson's. MD simulations provide microscopic insights into protein interactions and the subtleties of aggregation pathways, with advanced techniques like replica exchange molecular dynamics, Metadynamics (MetaD), and umbrella sampling enhancing our understanding by probing intricate energy landscapes and transition states. We delve into specific applications of MD simulations, elucidating the chaperone mechanism underlying cataract formation using Markov state modeling and the intricate pathways and interactions driving the toxic aggregate formation in Alzheimer's and Parkinson's disease. Transitioning we highlight how computational techniques, including bioinformatics, sequence analysis, structural data, machine learning algorithms, and artificial intelligence have become indispensable for predicting protein aggregation propensity and locating aggregation-prone regions within protein sequences. Throughout our exploration, we underscore the symbiotic relationship between computational approaches and empirical data, which has paved the way for potential therapeutic strategies against protein aggregation-related diseases. In conclusion, this review offers a comprehensive overview of advanced computational methodologies and bioinformatics tools that have catalyzed breakthroughs in unraveling the molecular basis of protein aggregation, with significant implications for clinical interventions, standing at the intersection of computational biology and experimental research.

Characterizing Prion‐Like Protein Aggregation: Emerging Nanopore‐Based Approaches

Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases

Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases

Fast Probing Amyloid Polymorphism via Nanopore Translocation

Intrinsic and Membrane-Facilitated Α-Synuclein Oligomerization Revealed by Label-Free Detection Through Solid-State Nanopores

Nanopore analysis of β-amyloid peptide aggregation transition induced by small molecules.

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Biological Nanopore Approach for Single‐Molecule Protein Sequencing

Label-free Detection of Early Oligomerization of Α-Synuclein and Its Mutants A30P/E46K Through Solid-State Nanopores.

Single Molecule Sensing of Amyloid-Β Aggregation by Confined Glass Nanopores

The allure and pitfalls of the prion-like aggregation in neurodegeneration

Nanopore single-molecule analysis of biomarkers: Providing possible clues to disease diagnosis

Prion-like Mechanisms in Alzheimer's Disease.

Experimental techniques for detecting and evaluating the amyloid fibrils

Prion-Like Mechanisms in Parkinson’s Disease

Nanopore Technology for the Application of Protein Detection

Solid-State and Biological Nanopore for Real-Time Sensing of Single Chemical and Sequencing of Dna

Advanced computational approaches to understand protein aggregation

Seed amplification and RT-QuIC assays to investigate protein seed structures and strains

Nanopore Detection Using Supercharged Polypeptide Molecular Carriers

Application of Solid-State Nanopore in Protein Detection